Emily Peterson Alva Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Emily Peterson Alva is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 211,029 shares of AMRX, which is worth approximately $1.58 Million. The most recent transaction as insider was on May 05, 2025, when has been sold 40,258 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K

15.85% 3M change

15.85% 12M change

Total Value Held $1.58 Million

Emily Peterson Alva Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 05 2025	BUY Exercise of conversion of derivative security	-	40,258 Added 16.02%	211,029 Class A Common Stock
Mar 05 2025	SELL Open market or private sale	$712,000 $8.9 p/Share	80,000 Reduced 31.9%	170,771 Class A Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	-	76,453 Added 23.36%	250,771 Class A Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	-	80,128 Added 31.49%	174,318 Class A Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	35,406 Added 27.32%	94,190 Class A Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	-	46,218 Added 44.02%	58,784 Class A Common Stock

Also insider at

ALKS

Alkermes plc. Healthcare

Director

EPA